Applying guidelines-directed therapies for antiplatelets and antithrombotics requires balancing the risks of cardiovascular events and the risk of bleeding. Guest Erin Michos, MD, MHS, FACC, FAHA, FASE, FASCP, describes the use of shared decision-making with patients who are at higher risk for thrombotic events and discusses pharmacotherapies recommended for use with particular patient groups.

Episode Resources

Topics

  • Acute Coronary Syndrome (ACS)
  • Pharmacology

Published on

August 29, 2023

Listen on: